Related Experiment Video
Updated: Aug 18, 2026

Indirect Immunofluorescence on Frozen Sections of Mouse Mammary Gland
Published on: December 1, 2015
WNT-1 and HGF regulate GSK3 beta activity and beta-catenin signaling in mammary epithelial cells
1Department of Molecular Oncology, Megabios Corporation, Burlingame, California 94010, USA.
Abstract:
Wnt-1, a secreted glycoprotein, participates in development of the nervous system and contributes to mammary oncogenesis when overexpressed. We show that GSK3 activity is decreased in mouse mammary cells transformed by Wnt-1. These cells also exhibit a substantial Wnt-1 dependent increase in the uncomplexed population of beta-catenin. Wnt-1 signaling does not change the steady state level of either GSK3 alpha or GSK3 beta but instead leads to an increased association between GSK3 beta and beta-catenin. HGF/SF treatment of mouse mammary cells also leads to a transient decrease in GSK3 activity and a parallel, selective increase in the uncomplexed pool of beta-catenin. Both Wnt-1 and HGF/SF lead to nuclear accumulation of beta-catenin and activation of a LEF/Tcf responsive reporter gene. This study defines a pivotal signal transduction pathway, activated by both Wnt-1 and HGF/SF, leading to decreased GSK3 beta activity and consequently an increase in the free pool and nuclear accumulation of beta-catenin and changes in gene expression.
Insights
Wnt-1 signaling reduces GSK3 activity, increasing beta-catenin. This pathway, also activated by HGF/SF, promotes nuclear beta-catenin accumulation and gene expression changes, impacting mammary oncogenesis.
Area of Science:
- Cellular signaling pathways
- Molecular biology
- Cancer research
Background:
- Wnt-1 is a secreted glycoprotein involved in nervous system development and mammary oncogenesis.
- Overexpression of Wnt-1 is linked to cancer development.
- GSK3 (Glycogen synthase kinase 3) plays a role in cellular regulation.
Purpose of the Study:
- To investigate the effect of Wnt-1 signaling on GSK3 activity and beta-catenin levels in mammary cells.
- To elucidate the signal transduction pathway activated by Wnt-1 and HGF/SF.
- To understand the downstream effects on gene expression.
Main Methods:
- Analysis of GSK3 activity in mouse mammary cells.
- Quantification of uncomplexed beta-catenin populations.
- Assessment of protein-protein interactions between GSK3 beta and beta-catenin.
- Treatment with Wnt-1 and HGF/SF.
- Monitoring of beta-catenin nuclear accumulation.
- Assay of LEF/Tcf responsive reporter gene activity.
Main Results:
- Wnt-1 transformation of mammary cells decreases GSK3 activity.
- Wnt-1 signaling leads to a Wnt-1 dependent increase in uncomplexed beta-catenin.
- Wnt-1 increases the association between GSK3 beta and beta-catenin without altering steady-state levels.
- HGF/SF treatment similarly causes a transient decrease in GSK3 activity and an increase in uncomplexed beta-catenin.
- Both Wnt-1 and HGF/SF induce nuclear accumulation of beta-catenin and activate LEF/Tcf responsive genes.
Conclusions:
- A key signal transduction pathway activated by Wnt-1 and HGF/SF involves decreased GSK3 beta activity.
- This pathway results in an increased free pool and nuclear accumulation of beta-catenin.
- The pathway ultimately leads to alterations in gene expression, relevant to mammary oncogenesis.
Related Concept Videos
Canonical Wnt Signaling Pathway
Hedgehog Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Regulation of Angiogenesis and Blood Supply
TGF - β Signaling Pathway
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...

